SCOPUS 정보 검색 플랫폼

Volumn 104, Issue 1, 2014, Pages 59-61

Efficacy and tolerability after 24 weeks of treatment with telaprevir, pegylated interferon and ribavirin in cirrhotic HIV-HCV coinfected subjects

(16) Genebat, Miguel a Vera, Francisco b Hernández Quero, José c Domingo, Pere d Guardiola, José M d Martínez Madrid, Onofre b Martínez, Lorena b De La Llana, Francisco García e Sánchez Villegas, Jorge f Álvarez, Hortensia g Mariño, Ana g Lluch, José F h Martínez Pérez, María A c Marín, Jorge e Ruiz Mateos, Ezequiel a Leal, Manuel a

a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO (Spain)

b Allergy Section (Spain)

c HOSPITAL UNIVERSITARIO SAN CECILIO (Spain)

d UNIVERSITAT AUTÒNOMA DE BARCELONA (Spain)

e HOSPITAL PERPETUO SOCORRO (Spain)

f Hospital La Merced (Spain)

g Universidad de La Coruña (Spain)

h HOSPITAL GENERAL DE LANZAROTE (Spain)

Author keywords

Hepatitis C virus; HIV; Liver cirrhosis; Telaprevir

Indexed keywords

HEPATITIS C VIRUS; HIV; LIVER CIRRHOSIS; TELAPREVIR;

ADOLESCENT; ADULT; AGED; ANTIVIRAL AGENTS; COINFECTION; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; INTERFERONS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; OLIGOPEPTIDES; RIBAVIRIN; TIME FACTORS; TREATMENT OUTCOME; VIRAL LOAD; YOUNG ADULT;

EID: 84894199686 PISSN: 01663542 EISSN: 18729096 Source Type: Journal
DOI: 10.1016/j.antiviral.2014.01.019 Document Type: Article

Times cited : (6)

References (12)

1
- 70349292099
- Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
- D. Ge, J. Fellay, A.J. Thompson, J.S. Simon, K.V. Shianna, T.J. Urban, E.L. Heinzen, P. Qiu, A.H. Bertelsen, A.J. Muir, M. Sulkowski, J.G. McHutchison, and D.B. Goldstein Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance Nature 461 2009 399 401
- (2009) Nature , vol.461 , pp. 399-401
- Ge, D.¹ Fellay, J.² Thompson, A.J.³ Simon, J.S.⁴ Shianna, K.V.⁵ Urban, T.J.⁶ Heinzen, E.L.⁷ Qiu, P.⁸ Bertelsen, A.H.⁹ Muir, A.J.¹⁰ Sulkowski, M.¹¹ McHutchison, J.G.¹² Goldstein, D.B.¹³

2
- 84882908504
- Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French early access programme (ANRS CO20-CUPIC) - NCT01514890
- CUPIC Study Group
- C. Hézode, H. Fontaine, C. Dorival, D. Larrey, F. Zoulim, V. Canva, V. de Ledinghen, T. Poynard, D. Samuel, M. Bourlière, J.P. Zarski, J.J. Raabe, L. Alric, P. Marcellin, G. Riachi, P.H. Bernard, V. Loustaud-Ratti, S. Métivier, A. Tran, L. Serfaty, A. Abergel, X. Causse, V. Di Martino, D. Guyader, D. Lucidarme, V. Grando-Lemaire, P. Hillon, C. Feray, T. Dao, P. Cacoub, I. Rosa, P. Attali, V. Petrov-Sanchez, Y. Barthe, J.M. Pawlotsky, S. Pol, F. Carrat, J.P. Bronowicki CUPIC Study Group Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French early access programme (ANRS CO20-CUPIC) - NCT01514890 J. Hepatol. 59 2013 434 441
- (2013) J. Hepatol. , vol.59 , pp. 434-441
- Hézode, C.¹ Fontaine, H.² Dorival, C.³ Larrey, D.⁴ Zoulim, F.⁵ Canva, V.⁶ De Ledinghen, V.⁷ Poynard, T.⁸ Samuel, D.⁹ Bourlière, M.¹⁰ Zarski, J.P.¹¹ Raabe, J.J.¹² Alric, L.¹³ Marcellin, P.¹⁴ Riachi, G.¹⁵ Bernard, P.H.¹⁶ Loustaud-Ratti, V.¹⁷ Métivier, S.¹⁸ Tran, A.¹⁹ Serfaty, L.²⁰ more..

3
- 79959438789
- Telaprevir for previously untreated chronic hepatitis C virus infection
- ADVANCE Study Team
- I.M. Jacobson, J.G. McHutchison, G. Dusheiko, A.M. Di Bisceglie, K.R. Reddy, N.H. Bzowej, P. Marcellin, A.J. Muir, P. Ferenci, R. Flisiak, J. George, M. Rizzetto, D. Shouval, R. Sola, R.A. Terg, E.M. Yoshida, N. Adda, L. Bengtsson, A.J. Sankoh, T.L. Kieffer, S. George, R.S. Kauffman, S. Zeuzem ADVANCE Study Team Telaprevir for previously untreated chronic hepatitis C virus infection N. Engl. J. Med. 364 2011 2405 2416
- (2011) N. Engl. J. Med. , vol.364 , pp. 2405-2416
- Jacobson, I.M.¹ McHutchison, J.G.² Dusheiko, G.³ Di Bisceglie, A.M.⁴ Reddy, K.R.⁵ Bzowej, N.H.⁶ Marcellin, P.⁷ Muir, A.J.⁸ Ferenci, P.⁹ Flisiak, R.¹⁰ George, J.¹¹ Rizzetto, M.¹² Shouval, D.¹³ Sola, R.¹⁴ Terg, R.A.¹⁵ Yoshida, E.M.¹⁶ Adda, N.¹⁷ Bengtsson, L.¹⁸ Sankoh, A.J.¹⁹ Kieffer, T.L.²⁰ more..

4
- 84879102536
- Efficacy and tolerance of telaprevir in HIV-hepatitis C virus genotype 1-coinfected patients failing previous antihepatitis C virus therapy: 24-week results
- K. Lacombe, N. Valin, H. Stitou, J. Gozlan, V. Thibault, A. Boyd, J.M. Poirier, J.L. Meynard, M.A. Valantin, J. Bottero, and P.M. Girard Efficacy and tolerance of telaprevir in HIV-hepatitis C virus genotype 1-coinfected patients failing previous antihepatitis C virus therapy: 24-week results AIDS 27 2013 1356 1359
- (2013) AIDS , vol.27 , pp. 1356-1359
- Lacombe, K.¹ Valin, N.² Stitou, H.³ Gozlan, J.⁴ Thibault, V.⁵ Boyd, A.⁶ Poirier, J.M.⁷ Meynard, J.L.⁸ Valantin, M.A.⁹ Bottero, J.¹⁰ Girard, P.M.¹¹

5
- 2642709177
- Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators
- F.J. Palella Jr, K.M. Delaney, A.C. Moorman, M.O. Loveless, J. Fuhrer, G.A. Satten, D.J. Aschman, and S.D. Holmberg Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators N. Engl. J. Med. 338 1998 853 860
- (1998) N. Engl. J. Med. , vol.338 , pp. 853-860
- Palella, Jr.F.J.¹ Delaney, K.M.² Moorman, A.C.³ Loveless, M.O.⁴ Fuhrer, J.⁵ Satten, G.A.⁶ Aschman, D.J.⁷ Holmberg, S.D.⁸

6
- 84876294731
- Limited impact of IL28B genotype on response rates in telaprevir-treated patients with prior treatment failure
- S. Pol, J. Aerssens, S. Zeuzem, P. Andreone, E.J. Lawitz, S. Roberts, Z. Younossi, G.R. Foster, R. Focaccia, A. Horban, P.J. Pockros, R.P. Van Heeswijk, S. De Meyer, D. Luo, M. Botfield, M. Beumont, and G. Picchio Limited impact of IL28B genotype on response rates in telaprevir-treated patients with prior treatment failure J. Hepatol. 58 2013 883 889
- (2013) J. Hepatol. , vol.58 , pp. 883-889
- Pol, S.¹ Aerssens, J.² Zeuzem, S.³ Andreone, P.⁴ Lawitz, E.J.⁵ Roberts, S.⁶ Younossi, Z.⁷ Foster, G.R.⁸ Focaccia, R.⁹ Horban, A.¹⁰ Pockros, P.J.¹¹ Van Heeswijk, R.P.¹² De Meyer, S.¹³ Luo, D.¹⁴ Botfield, M.¹⁵ Beumont, M.¹⁶ Picchio, G.¹⁷

7
- 80052826527
- Response-guided telaprevir combination treatment for hepatitis C virus infection
- ILLUMINATE Study Team
- K.E. Sherman, S.L. Flamm, N.H. Afdhal, D.R. Nelson, M.S. Sulkowski, G.T. Everson, M.W. Fried, M. Adler, H.W. Reesink, M. Martin, A.J. Sankoh, N. Adda, R.S. Kauffman, S. George, C.I. Wright, F. Poordad ILLUMINATE Study Team Response-guided telaprevir combination treatment for hepatitis C virus infection N. Engl. J. Med. 365 2011 1014 1024
- (2011) N. Engl. J. Med. , vol.365 , pp. 1014-1024
- Sherman, K.E.¹ Flamm, S.L.² Afdhal, N.H.³ Nelson, D.R.⁴ Sulkowski, M.S.⁵ Everson, G.T.⁶ Fried, M.W.⁷ Adler, M.⁸ Reesink, H.W.⁹ Martin, M.¹⁰ Sankoh, A.J.¹¹ Adda, N.¹² Kauffman, R.S.¹³ George, S.¹⁴ Wright, C.I.¹⁵ Poordad, F.¹⁶

8
- 77953913058
- Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study
- C. Smith, C.A. Sabin, J.D. Lundgren, R. Thiebaut, R. Weber, M. Law, Ad. Monforte, O. Kirk, N. Friis-Moller, A. Philips, P. Reiss, W. El Sadr, C. Pradier, and S.W. Worm Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study AIDS 24 2010 1537 1548
- (2010) AIDS , vol.24 , pp. 1537-1548
- Smith, C.¹ Sabin, C.A.² Lundgren, J.D.³ Thiebaut, R.⁴ Weber, R.⁵ Law, M.⁶ Monforte, Ad.⁷ Kirk, O.⁸ Friis-Moller, N.⁹ Philips, A.¹⁰ Reiss, P.¹¹ El Sadr, W.¹² Pradier, C.¹³ Worm, S.W.¹⁴

9
- 84879799809
- Combination therapy with telaprevir for chronic hepatitis C virus genotype 1 infection in patients with HIV: A randomized trial
- M.S. Sulkowski, K.E. Sherman, D.T. Dieterich, M. Bsharat, L. Mahnke, J.K. Rockstroh, S. Gharakhanian, S. McCallister, J. Henshaw, P.M. Girard, B. Adiwijaya, V. Garg, R.A. Rubin, N. Adda, and V. Soriano Combination therapy with telaprevir for chronic hepatitis C virus genotype 1 infection in patients with HIV: a randomized trial Ann. Intern. Med. 159 2013 86 96
- (2013) Ann. Intern. Med. , vol.159 , pp. 86-96
- Sulkowski, M.S.¹ Sherman, K.E.² Dieterich, D.T.³ Bsharat, M.⁴ Mahnke, L.⁵ Rockstroh, J.K.⁶ Gharakhanian, S.⁷ McCallister, S.⁸ Henshaw, J.⁹ Girard, P.M.¹⁰ Adiwijaya, B.¹¹ Garg, V.¹² Rubin, R.A.¹³ Adda, N.¹⁴ Soriano, V.¹⁵

10
- 3343012408
- Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients
- APRICOT Study Group
- F.J. Torriani, M. Rodríguez-Torres, J. Rockstroh, E. Lissen, J. González-García, A. Lazzarin, G. Carosi, J. Sasadeusz, C. Katlama, J. Montaner, H. Sette Jr, S. Passe, J. De Pamphilis, F. Duff, U.M. Schrenck, D.T. Dietricht APRICOT Study Group Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients N. Engl. J. Med. 351 2004 438 450
- (2004) N. Engl. J. Med. , vol.351 , pp. 438-450
- Torriani, F.J.¹ Rodríguez-Torres, M.² Rockstroh, J.³ Lissen, E.⁴ González-García, J.⁵ Lazzarin, A.⁶ Carosi, G.⁷ Sasadeusz, J.⁸ Katlama, C.⁹ Montaner, J.¹⁰ Sette, Jr.H.¹¹ Passe, S.¹² De Pamphilis, J.¹³ Duff, F.¹⁴ Schrenck, U.M.¹⁵ Dietricht, D.T.¹⁶

11
- 84875275752
- Effect of HCV infection on cause-specific mortality after HIV seroconversion, before and after 1997
- CASCADE Collaboratio in Eurocoord
- J. van der Helm, R. Geskus, C. Sabin, L. Meyer, J. del Amo, G. Chéne, M. Dorrucci, R. Muga, K. Porter, M. Prins CASCADE Collaboratio in Eurocoord Effect of HCV infection on cause-specific mortality after HIV seroconversion, before and after 1997 Gastroenterology 144 2013 751 760
- (2013) Gastroenterology , vol.144 , pp. 751-760
- Van Der Helm, J.¹ Geskus, R.² Sabin, C.³ Meyer, L.⁴ Del Amo, J.⁵ Chéne, G.⁶ Dorrucci, M.⁷ Muga, R.⁸ Porter, K.⁹ Prins, M.¹⁰

12
- 79959381354
- Telaprevir for retreatment of HCV infection
- REALIZE Study Team
- S. Zeuzem, P. Andreone, S. Pol, E. Lawitz, M. Diago, S. Roberts, R. Focaccia, Z. Younossi, G.R. Foster, A. Horban, P. Ferenci, F. Nevens, B. Müllhaupt, P. Pockros, R. Terg, D. Shouval, B. van Hoek, O. Weiland, R. Van Heeswijk, S. De Meyer, D. Luo, G. Boogaerts, R. Polo, G. Picchio, M. Beurmont REALIZE Study Team Telaprevir for retreatment of HCV infection N. Engl. J. Med. 364 2011 2417 2428
- (2011) N. Engl. J. Med. , vol.364 , pp. 2417-2428
- Zeuzem, S.¹ Andreone, P.² Pol, S.³ Lawitz, E.⁴ Diago, M.⁵ Roberts, S.⁶ Focaccia, R.⁷ Younossi, Z.⁸ Foster, G.R.⁹ Horban, A.¹⁰ Ferenci, P.¹¹ Nevens, F.¹² Müllhaupt, B.¹³ Pockros, P.¹⁴ Terg, R.¹⁵ Shouval, D.¹⁶ Van Hoek, B.¹⁷ Weiland, O.¹⁸ Van Heeswijk, R.¹⁹ De Meyer, S.²⁰ more..

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.